Paulo Ferreira

Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

Tiago Torres, L. Puig, Ronald Vender et al. · American Journal of Clinical Dermatology · 2021 · 116 citations · Full text

Medicine, Dermatology, Immunology +16

Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study

Tiago Torres, L. Puig, Ronald Vender et al. · American Journal of Clinical Dermatology · 2022 · 75 citations · Full text

Medicine, Dermatology, Immunology +16

Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study

Andrea Chiricozzi, Anna Balato, Curdin Conrad et al. · Journal of Dermatological Treatment · 2019 · 42 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Age affects drug survival rates of interleukin (<scp>IL</scp>)‐17 and <scp>IL</scp>‐23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi‐country, cohort study

Andrea Chiricozzi, Giulia Coscarella, L. Puig et al. · Journal of the European Academy of Dermatology and Venereology · 2024 · 13 citations

Education, Pharmacology, Pharmacotherapy +13

Epidemiology of Psoriasis in Portugal: A Population-Based Study

Tiago Torres, Paulo Filipe, Francisco Menezes Brandão et al. · Acta Médica Portuguesa · 2023 · 12 citations · Full text

Medicine, Dermatology, Clinical Epidemiology +13